Medicine and Dentistry
Patient
100%
Inpatient
59%
Patient with Inflammatory Bowel Disease
25%
Odds Ratio
24%
Association
23%
Prevalence
23%
Combination Therapy
22%
Neoplasm
22%
Complication
22%
Population
22%
Age
21%
Symptom
20%
Infliximab
19%
Endoscopy
19%
Colorectal Adenoma
17%
Inflammatory Bowel Disease
16%
Obesity
16%
Colonoscopy
16%
Colorectal Tumor
15%
Diagnosis
15%
Esophagus
15%
Adenoma
15%
Case-Control Study
15%
Colorectal Cancer
14%
Protective Factor
14%
Upper Gastrointestinal Bleeding
14%
MALT Lymphoma
14%
Screening
13%
Disease
13%
Cross Sectional Study
13%
Incidence
13%
Development
12%
Crohn's Disease
10%
Experience
10%
Ulcerative Colitis
10%
Ankylosing Spondylitis
10%
Polyp
10%
Metabolic Syndrome
10%
Intestine Preparation
10%
Follow up
10%
Health
10%
Tumor Necrosis Factor
10%
Midazolam
9%
Warfarin
9%
Irritable Bowel Syndrome
9%
Percutaneous Endoscopic Gastrostomy
9%
Endoscopic Retrograde Cholangiopancreatography
9%
Prostate
9%
Gallbladder
9%
Urge Incontinence
9%
Nursing and Health Professions
Midazolam
14%
Complication
11%
Prevalence
11%
Adenoma
10%
Vaccination Policy
9%
Combination Therapy
9%
Infliximab
9%
Biosimilar Agent
9%
Sedative Agent
9%
Population
8%
Adverse Event
7%
Colonoscopy
6%
Colorectal Adenoma
6%
Time
6%
Liver Cirrhosis
6%
Symptom
6%
Endoscopy
5%
Ulcerative Colitis
5%
Epidemiology
5%
Crohn Disease
5%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammatory Bowel Disease
15%
Colorectal Adenoma
14%
Adenoma
12%
Obesity
11%
Warfarin
9%
Infliximab
9%
Upper Gastrointestinal Bleeding
9%
Biosimilar Agent
9%
Adverse Event
9%
Symptom
8%
Prevalence
7%
Ulcerative Colitis
7%
Crohn Disease
7%
Complication
6%
Rheumatoid Arthritis
5%
Blindness
5%
Ankylosing Spondylitis
5%
Dyspepsia
5%
Incidence
5%
